Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 19, 2011Antimicrobial Agents and ChemotherapyOpen Access

DNA Gyrase Inhibition Assays Are Necessary To Demonstrate Fluoroquinolone Resistance Secondary to gyrB Mutations in Mycobacterium tuberculosis

View Full Paper
Ask AI
Bookmark
Share

Authors

APAlix PantelSPS. PetrellaSMStéphanie Matrat

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Pantel et al. (2011) studied this question.

synapsesocial.com/papers/69d7e674a2a48916bbbee3b2https://doi.org/10.1128/aac.00707-11
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosisisolates from East China in 20092011 · 54 citations
  2. 2Role of mycobacterial efflux transporters in drug resistance: an unresolved question2005 · 333 citations
  3. 3Quinolone Antimicrobial Agents. 3rd Ed.2004 · 58 citations
  4. 4Escherichia coli Mutants Thermosensitive for Deoxyribonucleic Acid Gyrase Subunit A: Effects on Deoxyribonucleic Acid Replication, Transcription, and Bacteriophage Growth1979 · 337 citations
  5. 5Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis2004 · 337 citations